Pure Biologics (Poland) Price on December 12, 2024
| PUR Stock | 17.10 3.10 22.14% |
If you're considering investing in Pure Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pure Biologics stands at 17.10, as last reported on the 17th of December 2024, with the highest price reaching 17.10 and the lowest price hitting 14.60 during the day. Pure Biologics Splka maintains Sharpe Ratio (i.e., Efficiency) of -0.0611, which implies the firm had a -0.0611% return per unit of risk over the last 3 months. Pure Biologics Splka exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pure Biologics' Coefficient Of Variation of (1,428), variance of 27.2, and Risk Adjusted Performance of (0.04) to confirm the risk estimate we provide.
Pure Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pure |
Sharpe Ratio = -0.0611
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PUR |
Estimated Market Risk
| 4.98 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.3 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pure Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pure Biologics by adding Pure Biologics to a well-diversified portfolio.
Pure Biologics Valuation on December 12, 2024
It is possible to determine the worth of Pure Biologics on a given historical date. On December 12, 2024 Pure was worth 13.52 at the beginning of the trading date compared to the closed value of 13.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pure Biologics stock. Still, in general, we apply an absolute valuation method to find Pure Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pure Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pure Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 14.70 | 14.76 | 13.38 | 13.56 | 88,783 | |
12/12/2024 | 13.52 | 14.78 | 13.10 | 13.78 | 102,999 |
| 13.52 | 14.24 | 13.50 | 14.00 | 38,977 |
| Backtest Pure Biologics | | | Pure Biologics History | Previous | Next |
Pure Biologics Trading Date Momentum on December 12, 2024
| On December 13 2024 Pure Biologics Splka was traded for 14.00 at the closing time. The highest price during the trading period was 14.24 and the lowest recorded bid was listed for 13.50 . The volume for the day was 39 K. This history from December 13, 2024 contributed to the next trading day price gain. The trading delta at closing time to the next closing price was 1.60% . The trading delta at closing time to the current price is 5.95% . |
Price Boundaries
Pure Biologics Period Price Range
Low | December 17, 2024
| High |
0.00 | 0.00 |
Pure Biologics Splka cannot be verified against its exchange. Please verify the symbol is currently traded on Warsaw Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pure Biologics December 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Pure Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pure Biologics shares will generate the highest return on investment. By undertsting and applying Pure Biologics stock market strength indicators, traders can identify Pure Biologics Splka entry and exit signals to maximize returns
Pure Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pure Biologics' price direction in advance. Along with the technical and fundamental analysis of Pure Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pure to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | 0.274 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Pure Stock Analysis
When running Pure Biologics' price analysis, check to measure Pure Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Biologics is operating at the current time. Most of Pure Biologics' value examination focuses on studying past and present price action to predict the probability of Pure Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Biologics' price. Additionally, you may evaluate how the addition of Pure Biologics to your portfolios can decrease your overall portfolio volatility.